Autumn Essay
Release time:
2020-07-22
Autumn Essay
has been away from Luoyang for a long time. When it comes to autumn, I will still miss the ginkgo trail. First, the autumn wind turns yellow, and then the rain turns golden. Now back to the south, the power of the autumn wind has dropped sharply, blowing not only the evergreen broad leaves, but also the bushes on the roadside. If it were not for the rapid drop in temperature at night, it would be almost impossible to detect that autumn has arrived.
saw the message that popped up in the group that had not moved for a long time. Friends in the north announced that they had put on long Johns. Only then did they know that time went fast and we also went far. Six months ago we looked up at the same starry sky, six months later we breathe different air. I want to say "miss you" and can't say it again, which makes me melodramatic, but if I don't say it, it seems that I can no longer open my mouth, open my mouth, and moss crawls out of my tongue.
How are we all doing? Although this is not the first time we have parted, we keep going from one place to another, and our friends and classmates keep going from one place to another, just like leeks that have been collected according to the change of seasons. Sometimes when I think about it, I just feel like a relay. The baton called "friendship" is handed from your hand to mine. Then it's my turn to run away. I take this baton and run to him again. Looking back, you are still in place, but you are no longer together. This kind of feeling is not good or bad, but sometimes I want to find you, want to find him, and I don't know how to speak. This kind of emotion turns into a code, a string of words, a screen of pixels, beating on this end of the mobile phone, but the other end of the mobile phone, with its bright and dark head, is moving and running on their own runway.
People come and go alone and are born lonely. I always thought so. Whether it is happy or unhappy, slowly no longer pull others to share, understand that everyone is very busy, but also understand that no one can really feel the same. A person facing those emotions, happy or sad, brewing and tasting, also has a different taste. Is this what it feels like to grow up?
With these words written on it, I couldn't help laughing. The sun is gradually sinking towards the other end of the mountain, and the temperature is gradually cooling. Friends who are scattered, please remember to add clothes! (wang junxiao)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31